Nucleai Brings AI-powered spatial biology technology to the forefront of precision medicine to improve drug development, clinical treatment decisions, and patient outcomes.
Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
Nucleai’s Atom: The leading Spatial Biology Platform for Precision Medicine.
Company Details
- Employees
- 79
- Founded
- 2018
- Address
- Chicago, Il, Us
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- nucleaimd.com
- Keywords
- Pharma, Biomarker Development, Biomarker Discovery, Big Data, Machine Learning, CDx, Digital Pathology, Immunotherapy, Spatial biology, Precision Medicine.
- HQ
- Chicago, IL
- Competitors
- Imagene, K Health, Navina, Aidoc, Protai, Immunai, Viz.ai, MeMed, Healthy.io, CytoReason.
Nucleai Questions
Nucleai's website is nucleaimd.com
Nucleai's LinkedIn profile is https://il.linkedin.com/company/nucleai-ai
Nucleai has
79 employees.
View email and phone details for 79
employees at Nucleai.
Nucleai's industry is
Software Development
Nucleai's top competitors are
Imagene,
K Health,
Navina,
Aidoc,
Protai,
Immunai,
Viz.ai,
Memed,
Healthy.io,
Cytoreason.
Nucleai's categories are Software Development
Nucleai's founding year is 2018
